Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Suzanne S, Farid"'
Autor:
Stephen Goldrick, Haneen Alosert, Clare Lovelady, Nicholas J. Bond, Tarik Senussi, Diane Hatton, John Klein, Matthew Cheeks, Richard Turner, James Savery, Suzanne S. Farid
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 11 (2023)
Cell line development is an essential stage in biopharmaceutical development that often lies on the critical path. Failure to fully characterise the lead clone during initial screening can lead to lengthy project delays during scale-up, which can pot
Externí odkaz:
https://doaj.org/article/b8b9e6ce0bbe496d96efa8a7b7ef2a67
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 20, Iss , Pp 1811-1820 (2022)
Machine learning is an important artificial intelligence technique that is widely applied in cancer diagnosis and detection. More recently, with the rise of personalised and precision medicine, there is a growing trend towards machine learning applic
Externí odkaz:
https://doaj.org/article/4929c8913c4944b2b5f1d285a5536b68
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 19, Iss , Pp 2750-2760 (2021)
Conformational stability of a protein is usually obtained by spectroscopically measuring the unfolding melting temperature. However, optical spectra under native conditions are considered to contain too little resolution to probe protein stability. H
Externí odkaz:
https://doaj.org/article/1aa9c8be4fa84d1aa1767f52fd44cfd3
Publikováno v:
mAbs, Vol 12, Iss 1 (2020)
This study aims to benchmark and analyze the process development and manufacturing costs across the biopharmaceutical drug development cycle and their contribution to overall research and development (R&D) costs. This was achieved with a biopharmaceu
Externí odkaz:
https://doaj.org/article/cdaa6cf7eb1642fc988d36a61e34199d
Autor:
Annabel Lyle, Christos Stamatis, Thomas Linke, Martyn Hulley, Albert Schmelzer, Richard Turner, Suzanne S. Farid
Publikováno v:
Biotechnology and Bioengineering.
Autor:
Christos Stamatis, Sherri-Ann Chalmers, Suzanne S. Farid, Eloy Erro, Clare Selden, Joana Mendonça da Silva
Publikováno v:
Cytotherapy. 23:683-693
Background aims Bioartificial liver devices (BALs) are categorized as advanced therapy medicinal products (ATMPs) with the potential to provide temporary liver support for liver failure patients. However, to meet commercial demands, next-generation B
Autor:
Steven Rose, Sevda Deldari, Maen Qadan, Lisa Connell-Crowley, Jonathan Coffman, Ujwal Patil, David Pollard, Joseph Shultz, Brian Horowski, Mark Brower, Suzanne S. Farid, Eugene Schaefer
Publikováno v:
Biotechnology and Bioengineering
There is a growing application of integrated and continuous bioprocessing (ICB) for manufacturing recombinant protein therapeutics produced from mammalian cells. At first glance, the newly evolved ICB has created a vast diversity of platforms. A clos
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 19, Iss, Pp 2750-2760 (2021)
Computational and Structural Biotechnology Journal
Computational and Structural Biotechnology Journal
Graphical abstract
Conformational stability of a protein is usually obtained by spectroscopically measuring the unfolding melting temperature. However, optical spectra under native conditions are considered to contain too little resolution to pr
Conformational stability of a protein is usually obtained by spectroscopically measuring the unfolding melting temperature. However, optical spectra under native conditions are considered to contain too little resolution to pr
Autor:
Matthew Lakelin, Suzanne S. Farid, Maria M. Papathanasiou, Christos Stamatis, Nigel J. Titchener-Hooker, Nilay Shah
Publikováno v:
Cancer Gene Therapy. 27:799-809
Chimeric antigen receptor (CAR) T cells are considered a potentially disruptive cancer therapy, showing highly promising results. Their recent success and regulatory approval (both in the USA and Europe) are likely to generate a rapidly increasing de
Publikováno v:
Regulation & Governance
The need to better balance the promotion of scientific and technological innovation with risk management for consumer protection has inspired several recent reforms attempting to make regulations more flexible and adaptive. The pharmaceutical sector
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9d1471446ae4307879dd0d47b4111fc
https://hdl.handle.net/11250/3059193
https://hdl.handle.net/11250/3059193